Literature DB >> 8798358

Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.

C J Weber1, J Russell, J T Chryssochoos, M Hagler, W C McGarity.   

Abstract

The purpose of this study was to clarify the pathophysiology of primary hyperparathyroidism by looking for differences between parathyroids from eucalcemic patients and patients with primary hyperparathyroidism (HPT) with respect to the following parameters: intracellular parathyroid content of parathyroid hormone (PTH) and parathyroid hormone messenger RNA (PTH mRNA); and serum PTH and calcium levels of patients and patient age. Coded samples of human parathyroid biopsies were assayed for PTH content with a C-terminal-specific radioimmunoassay. Total cellular RNA was extracted, and PTH mRNA was quantified by dot-blot analysis. These results were tabulated along with associated data on patient age, preoperative serum PTH, and preoperative calcium levels. The content of PTH was significantly higher in true normal (TN) parathyroids than in parathyroids from patients with hyperparathyroidism. PTH content of adenomas and hyperplasias were similar. PTH content of normal parathyroids biopsied from patients with parathyroid adenomas (NA) was statistically higher than that of adenomas but statistically lower than that of TN parathyroids. PTH mRNA and PTH content were correlated (p < 0.001) for TN parathyroid glands; however, it was not true for glands (grossly normal or otherwise) in patients with HPT. Patient groups were similar with regard to mean patient age and intracellular PTH mRNA levels. Hypercalcemic patients were similar with regard to preoperative serum calcium and PTH levels. NA parathyroids, adenomas, and hyperplasias are different from TN parathyroids with regard to their PTH content. PTH mRNA was similar across all groups. The relation between intracellular PTH mRNA and PTH was significantly absent in patients with HPT compared with TN glands. Furthermore, we have found that PTH content of normal parathyroid in patients with adenoma is similar to that of hyperplastic and adenoma tissues. These data suggest that the PTH content of parathyroid tissues may be of use in differentiating normal from abnormal parathyroids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798358     DOI: 10.1007/s002689900154

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  7 in total

1.  Intraoperative determination of PTH concentrations in fine needle tissue aspirates to identify parathyroid tissue during parathyroidectomy.

Authors:  János Horányi; László Duffek; Rezso Szlávik; István Takács; Miklós Tóth; László Romics
Journal:  World J Surg       Date:  2010-03       Impact factor: 3.352

2.  Normocalcemic primary hyperparathyroidism in patients with recurrent kidney stones: pathological analysis of parathyroid glands.

Authors:  An-Hang Yang; Chih-Wei Hsu; Jui-Yu Chen; Ling-Ming Tseng; Ging-Shing Won; Chen-Hsen Lee
Journal:  Virchows Arch       Date:  2006-05-03       Impact factor: 4.064

3.  Fine needle aspiration and intraparathyroid intact parathyroid hormone measurement for reoperative parathyroid surgery.

Authors:  Natacha K Kiblut; Jean-Félix Cussac; Benoît Soudan; Stephen G Farrell; John A Armstrong; Laurent Arnalsteen; Anne Biechlin; Alexis A Delattre; Charles A G Proye
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

4.  Immunocytochemical Localization of Prohormone Convertase 1/3 and 2 in Thyroid C-Cells and Medullary Thyroid Carcinomas.

Authors:  Tatsuo Tomita
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

5.  Diffuse parathyroid hormone expression in parathyroid tumors argues against important functional tumor subclones.

Authors:  Felix Haglund; C Christofer Juhlin; Nimrod B Kiss; Catharina Larsson; Inga-Lena Nilsson; Anders Höög
Journal:  Eur J Endocrinol       Date:  2016-02-10       Impact factor: 6.664

6.  Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.

Authors:  Lucie Canaff; Vito Guarnieri; Yoojung Kim; Betty Y L Wong; Alexis Nolin-Lapalme; David E C Cole; Salvatore Minisola; Cristina Eller-Vainicher; Filomena Cetani; Andrea Repaci; Daniela Turchetti; Sabrina Corbetta; Alfredo Scillitani; David Goltzman
Journal:  Eur J Endocrinol       Date:  2022-02-04       Impact factor: 6.664

7.  Immunocytochemical staining patterns for parathyroid hormone and chromogranin in parathyroid hyperplasia, adenoma, and carcinoma.

Authors:  T Tomita
Journal:  Endocr Pathol       Date:  1999-06       Impact factor: 4.056

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.